Ersbøll J, Schultz H B, Hougaard P, Nissen N I, Hou-Jensen K
Cancer. 1985 May 15;55(10):2442-58. doi: 10.1002/1097-0142(19850515)55:10<2442::aid-cncr2820551024>3.0.co;2-9.
Six hundred fifty-eight cases of previously untreated non-Hodgkin's lymphoma seen between 1970 and 1979 at the Medical Department, the Finsen Institute, were the basis for a comparative study of the prognostic value of the Rappaport, Kiel, and Lukes & Collins classifications and the new translation system, the Working Formulation of Non-Hodgkin's Lymphoma. Each histopathologic system proved equally effective in separating patients into subgroups with a spectrum of prognoses ranging from a median survival of less than 1 year to greater than 7 years. The established classifications were compared with the Working Formulation in order to evaluate its translational value. The Working Formulation was more similar to the Rappaport and the Lukes & Collins systems than to the Kiel system, since 82%, 89%, and 75% of the cases, respectively, were translatable following the guidelines outlined in the National Cancer Institute (NCI)-sponsored study. Similarities among the four systems were demonstrated in lymphomas with follicular growth pattern, and in diffuse lymphomas composed of small mature appearing lymphocytes or small cleaved lymphocytes. Incongruity among the systems was more marked in lymphomas composed of large lymphoid cells or in lymphomas of mixed cellular composition. A comparison was performed for each classification against the Working Formulation. All such subdivided subsets were tested for prognostic heterogeneity and the following conclusions were reached: the diffuse poorly differentiated lymphocytic category of Rappaport was separated into two subgroups (malignant lymphoma [ML] small cleaved cell and ML lymphoblastic) with different prognoses (P = 0.01); the diffuse "histiocytic" lymphomas were prognostically homogeneous, since none of the newer systems were able to identify subpopulations with significantly different prognoses; the subtypes of the Kiel classification were prognostically homogeneous; the only weakness of the Lukes & Collins classification was the undefined cell subtype, encompassing two populations with different prognoses; and (5) the importance of follicular growth pattern was confirmed for small cleaved cell and mixed cell cytology, whereas large cell cytology implied a poor prognosis regardless of pattern. By the use of the Cox regression model it could be demonstrated that the Working Formulation can substitute any of the established classifications in terms of prognostic value.
1970年至1979年间,芬森研究所医学部收治了658例未经治疗的非霍奇金淋巴瘤患者,以此为基础对拉帕波特分类法、基尔分类法、卢克斯和柯林斯分类法以及新的分类系统——非霍奇金淋巴瘤工作分类法的预后价值进行了比较研究。每种组织病理学系统在将患者分为预后范围从中位生存期不到1年到超过7年不等的亚组方面都同样有效。将已有的分类法与工作分类法进行比较,以评估其转化价值。工作分类法与拉帕波特分类法和卢克斯与柯林斯分类法比与基尔分类法更为相似,因为按照美国国立癌症研究所(NCI)资助研究中概述的指南,分别有82%、89%和75%的病例可以进行转化。在具有滤泡生长模式的淋巴瘤以及由小的成熟淋巴细胞或小的裂细胞组成的弥漫性淋巴瘤中,四种分类系统之间的相似性得到了体现。在由大淋巴细胞组成的淋巴瘤或混合细胞成分的淋巴瘤中,各系统之间的不一致更为明显。对每种分类法与工作分类法进行了比较。对所有这些细分的亚组进行了预后异质性测试,得出以下结论:拉帕波特分类法中的弥漫性低分化淋巴细胞类别被分为两个预后不同的亚组(恶性淋巴瘤[ML]小裂细胞和ML淋巴母细胞)(P = 0.01);弥漫性“组织细胞性”淋巴瘤在预后上是同质的,因为没有一种新系统能够识别出预后有显著差异的亚群;基尔分类法的亚型在预后上是同质的;卢克斯与柯林斯分类法的唯一弱点是未定义的细胞亚型,包括两个预后不同的群体;(5)对于小裂细胞和混合细胞细胞学,滤泡生长模式的重要性得到了证实,而大细胞细胞学无论其模式如何都意味着预后不良。通过使用Cox回归模型可以证明,就预后价值而言,工作分类法可以替代任何已有的分类法。